the aid library

LIST OPTIONS

Filter

2112

EQUINET Information sheet on COVID-19

R Loewenson EQUINET (2020) C1

Produced by Training and Research Support Centre for the Regional Network for Equity in Health in east and southern Africa (EQUINET), March 20, 2020. This brief summarises and provides links to official, scientific and other resources to support an understanding of and individual to regional level... more

Download (333)

View PDF (364)

Hypertension and COVID-19

World Health Organization WHO (2021) C_WHO

Scientific Brief, 17 June 2021

Download (172)

View PDF (226)

Standard treatment guidelines medicine ( Non Respiratory Infectious Medical Conditions) India

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr. 6, 2020

Download (188)

View PDF (203)

Mali national action plan on antimicrobial resistance: review of progress in the human health sector

World Health Organisation (WHO) (2023) C_WHO

This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act... more

External Link

Finding the Missing Tuberculosis Patients

D. P. Chin, C. L. Hanson The Journal of Infectious Disease; IDSA; Oxford, et al. (2017) C2

Supplement article The Journal of Infectious Diseases® 2017;216(S7):S675–8 DOI: 10.1093/infdis/jix368 Finding the Missing Tuberculosis Patients • JID 2017:216 (Suppl 7) • S675 Downloaded from https://academic.oup.com/jid/article-abstract/216/suppl_7/S675/4595547 by guest on 13 Nove... more

Download (250)

View PDF (230)

Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration

E. J. Abrams; J. Ananworanich; M. Archary; M.N. Ngongondo; P. Brouwers J Acquir Immune Defic Syndr; Pub Med (2018) C2

J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018

External Link

Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study

L. R. Augustemak de Lima; E. L. Petroski; Y. M. F. Moreno; et al. PLOS ONE (2018) CC

Research Article PLOS ONE | https://doi.org/10.1371/journal.pone.0190785 January 10, 2018

External Link

Forecast analysis of any opportunistic infection among HIV positive individuals on antiretroviral therapy in Uganda

Rubaihayo, J., N.M. Tumwesigye, J. Konde-Lule, et al. BMC Public Health (2016) CC

BMC Public Health (2016) 16:766 DOI 10.1186/s12889-016-3455-5

Download (82)

View PDF (57)

Schistosomiasis diagnosis: Challenges and opportunities for elimination

Ally O, Kanoi BN, Ochola L, et al. (2024) CC

PLoS Negl Trop Dis 18(7): e0012282. This review highlights common diagnostic approaches for detecting schistosomiasis in field and clinical settings, major challenges, and provides new and novel opportunities and diagnosis pathways that will be critical in sup- porting elimination of schistosomi... more

Download (53)

View PDF (57)

Evaluation of serum-based real-time PCR to detect Schistosoma mansoni infection before and after treatment

Fuss, A.; H. D. Mazigo and A. Mueller (2020) CC

Infectious Diseases of Poverty (2020) 9:74 To detect acute schistosomiasis, low-intensity infections, or to verify the success of treatment with praziquantel, highly sensitive test methods are required. The aim of this study was therefore to demonstrate the performance of Schistosoma mansoni spec... more

Download (1606)

View PDF (1850)

A Framework for Integrating Childhood Tuberculosis into Community-based Child Health Care

Detjen A, Gnanashanmugam D, Talens A International Union Against Tuberculosis and Lung Disease (The Union), CORE Group (2013) C_WHO

External Link

Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous Mycobacterioses

N. Schoenfeld, W. Haas, E. Richter, et al. (2016) C2

Empfehlungen zur Diagnostik und Therapie nichttuberkulöser Mykobakteriosen des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Schönfeld N et al. Recommendations of the German Central Committee… Pneumolo... more

Download (103)

View PDF (94)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

External Link

Novel vaccination approaches to prevent tuberculosis in children

J. A. Triccas, C. Counoupas Pneumonia; BioMed Central (2016) CC

Review Triccas and Counoupas Pneumonia (2016) 8:18; DOI 10.1186/s41479-016-0020-z

Download (280)

View PDF (259)

Policy brief on tuberculosis-associated disability

World Health Organization WHO (2023) C_WHO

People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ... more

External Link

Transmission dynamics and control of Ebola virus disease (EVD): a review

Chowell and Nishiura (2014)

BMC Medicine 2014, 12:196 http://www.biomedcentral.com/1741-7015/12/196

Download (290)

View PDF (302)

European nurse: Information and communication guide on microbes

European specialist nurse organisation (ESN) (2020) C2

This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR, infection prevention and control. It will support nurses on better action and also on communication towards their patients and families.

External Link

Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas

Suárez, C., Nolder, D., García-Mingo, A. et al. Research and reports in tropical medicine (2022) CC

Research and Reports in Tropical Medicine 2022:13 25–40. Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po... more

Download (628)

View PDF (769)

Namibia: STANDARD GUIDELINES ON INFECTION PREVENTION CONTROL IN DENTAL SURGERY

Ministry of Health and Social Services (MOHSS) (2012) C1

Oral Health and Dental Services

Download (291)

View PDF (522)

TB/HIV integration

AIDS and Rights Alliance for Southern Africa (2017) C2

TB heroes Hello, my name is Nurse X My job is to promote integrated HIV and TB prevention, care, treatment and support. This ensures that we, and my team of health care service providers treat everyone who is living with HIV and TB to have all the antiretroviral therapy (ART) and HIV care services... more